Ascendis Pharma AS (ASND)
122.73
-1.65
(-1.33%)
USD |
NASDAQ |
Nov 21, 16:00
122.73
0.00 (0.00%)
After-Hours: 18:40
Ascendis Pharma Market Cap: 7.334B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 7.433B |
| November 19, 2024 | 7.437B |
| November 18, 2024 | 7.291B |
| November 15, 2024 | 7.560B |
| November 14, 2024 | 7.427B |
| November 13, 2024 | 7.532B |
| November 12, 2024 | 7.630B |
| November 11, 2024 | 7.673B |
| November 08, 2024 | 7.430B |
| November 07, 2024 | 7.563B |
| November 06, 2024 | 7.731B |
| November 05, 2024 | 7.657B |
| November 04, 2024 | 7.516B |
| November 01, 2024 | 7.487B |
| October 31, 2024 | 7.340B |
| October 30, 2024 | 7.339B |
| October 29, 2024 | 7.576B |
| October 28, 2024 | 7.735B |
| October 25, 2024 | 7.788B |
| October 24, 2024 | 7.757B |
| October 23, 2024 | 7.631B |
| October 22, 2024 | 7.713B |
| October 21, 2024 | 7.689B |
| October 18, 2024 | 7.763B |
| October 17, 2024 | 7.569B |
| Date | Value |
|---|---|
| October 16, 2024 | 7.787B |
| October 15, 2024 | 7.607B |
| October 14, 2024 | 7.677B |
| October 11, 2024 | 7.701B |
| October 10, 2024 | 7.789B |
| October 09, 2024 | 7.727B |
| October 08, 2024 | 7.891B |
| October 07, 2024 | 8.315B |
| October 04, 2024 | 8.526B |
| October 03, 2024 | 8.423B |
| October 02, 2024 | 8.742B |
| October 01, 2024 | 8.761B |
| September 30, 2024 | 8.923B |
| September 27, 2024 | 8.643B |
| September 26, 2024 | 8.790B |
| September 25, 2024 | 8.725B |
| September 24, 2024 | 8.643B |
| September 23, 2024 | 8.745B |
| September 20, 2024 | 8.675B |
| September 19, 2024 | 8.799B |
| September 18, 2024 | 8.538B |
| September 17, 2024 | 8.407B |
| September 16, 2024 | 8.004B |
| September 13, 2024 | 6.837B |
| September 12, 2024 | 6.527B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.933B
Minimum
Apr 28 2023
9.762B
Maximum
Dec 14 2020
6.860B
Average
6.886B
Median
Feb 07 2020
Market Cap Benchmarks
| Novo Nordisk AS | 456.05B |
| Evaxion Biotech AS | 8.037M |
| Trinity Biotech PLC | 12.12M |
| Biodexa Pharmaceuticals PLC | 2.532M |
| NuCana PLC | 2.853M |
Market Cap Related Metrics
| PS Ratio | 19.74 |
| Price | 122.73 |
| Earnings Yield | -6.60% |